The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Cd1-Restricted Nk T Cells Protect Nonobese Diabetic Mice from Developing Diabetes
Open accessAbstract
NK T cells are a unique subset of T cells that recognize lipid antigens presented by CD1d. After activation, NK T cells promptly produce large amounts of cytokines, which may modulate the upcoming immune responses. Previous studies have documented an association between decreased numbers of NK T cells and the progression of some autoimmune diseases, suggesting that NK T cells may control the development of autoimmune diseases. To investigate the role of NK T cells in autoimmune diabetes, we crossed CD1 knockout (CD1KO) mutation onto the nonobese diabetic (NOD) genetic background. We found that male CD1KO NOD mice exhibited significantly higher incidence and earlier onset of diabetes compared with the heterozygous controls. The diabetic frequencies in female mice showed a similar pattern; however, the differences were less profound between female CD1KO and control mice. Early treatment of NOD mice with α-galactosylceramide, a potent NK T cell activator, reduced the severity of autoimmune diabetes in a CD1-dependent manner. Our results not only suggest a protective role of CD1-restricted NK T cells in autoimmune diabetes but also reveal a causative link between the deficiency of NK T cells and the induction of insulin-dependent diabetes mellitus.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CD1d-Restricted and TCR-Mediated Activation of V α 14 NKT Cells by Glycosylceramides
Kawano, T., Cui, J., Koezuka, Y., Toura, I., Kaneko, Y., Motoki, K., Ueno, H., Nakagawa, R., Sato, H., Kondo, E., et al. (1997) · Science · doi:10.1126/science.278.5343.1626 · Cited by 2,400
Salomon, B., Lenschow, D. J., Rhee, L., Ashourian, N., Singh, B., Sharpe, A., & Bluestone, J. A. (2000) · Immunity · doi:10.1016/s1074-7613(00)80195-8 · Cited by 2,081
MOUSE CD1-SPECIFIC NK1 T CELLS: Development, Specificity, and Function
Bendelac, A., Rivera, M. N., Park, S.-H., & Roark, J. H. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.535 · Cited by 1,326
Requirement for V α 14 NKT Cells in IL-12-Mediated Rejection of Tumors
Cui, J., Shin, T., Kawano, T., Sato, H., Kondo, E., Toura, I., Kaneko, Y., Koseki, H., Kanno, M., & Taniguchi, M. (1997) · Science · doi:10.1126/science.278.5343.1623 · Cited by 1,237
NKT cells: facts, functions and fallacies
Godfrey, D. I., Hammond, K. J. L., Poulton, L. D., Smyth, M. J., & Baxter, A. G. (2000) · Immunology Today · doi:10.1016/s0167-5699(00)01735-7 · Cited by 858
Carnaud, C., Lee, D., Donnars, O., Park, S.-H., Beavis, A., Koezuka, Y., & Bendelac, A. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.9.4647 · Cited by 854
Differential Tumor Surveillance by Natural Killer (Nk) and Nkt Cells
Smyth, M. J., Thia, K. Y. T., Street, S. E. A., Cretney, E., Trapani, J. A., Taniguchi, M., Kawano, T., Pelikan, S. B., Crowe, N. Y., & Godfrey, D. I. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.4.661 · Cited by 829
The Nonobese Diabetic Mouse as a Model of Autoimmune Diabetes: Immune Dysregulation Gets the NOD
Delovitch, T. L., & Singh, B. (1997) · Immunity · doi:10.1016/s1074-7613(00)80392-1 · Cited by 676
Extreme Th1 bias of invariant Vα24JαQ T cells in type 1 diabetes
Wilson, S. B., Kent, S. C., Patton, K. T., Orban, T., Jackson, R. A., Exley, M., Porcelli, S., Schatz, D. A., Atkinson, M. A., Balk, S. P., et al. (1998) · Nature · doi:10.1038/34419 · Cited by 646
Brossay, L., Chioda, M., Burdin, N., Koezuka, Y., Casorati, G., Dellabona, P., & Kronenberg, M. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.8.1521 · Cited by 642
Kitamura, H., Iwakabe, K., Yahata, T., Nishimura, S.-I., Ohta, A., Ohmi, Y., Sato, M., Takeda, K., Okumura, K., Van Kaer, L., et al. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.7.1121 · Cited by 626
T Helper Cell Subsets in Insulin-Dependent Diabetes
Katz, J. D., Benoist, C., & Mathis, D. (1995) · Science · doi:10.1126/science.7761837 · Cited by 593
Genetic Control of Autoimmune Diabetes in the NOD Mouse
Wicker, L. S. (1995) · Annual Review of Immunology · doi:10.1146/annurev.immunol.13.1.179 · Cited by 589
Natural Killer T Cell Activation Inhibits Hepatitis B Virus Replication in Vivo
Kakimi, K., Guidotti, L. G., Koezuka, Y., & Chisari, F. V. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.7.921 · Cited by 584
Bendelac, A., Carnaud, C., Boitard, C., & Bach, J. F. (1987) · The Journal of experimental medicine · doi:10.1084/jem.166.4.823 · Cited by 569
Requirements for CD1d Recognition by Human Invariant Vα24+ CD4−CD8− T Cells
Exley, M., Garcia, J., Balk, S. P., & Porcelli, S. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.1.109 · Cited by 531
The Murine Autoimmune Diabetes Model: NOD and Related Strains
Kikutani, H., & Makino, S. (1992) · Advances in Immunology · doi:10.1016/s0065-2776(08)60490-3 · Cited by 496
Impaired NK1+ T Cell Development and Early IL-4 Production in CD1-Deficient Mice
Chen, Y.-H., Chiu, N. M., Mandal, M., Wang, N., & Wang, C.-R. (1997) · Immunity · doi:10.1016/s1074-7613(00)80289-7 · Cited by 486
Self-citationKawano, T., Cui, J., Koezuka, Y., Toura, I., Kaneko, Y., Sato, H., Kondo, E., Harada, M., Koseki, H., Nakayama, T., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.10.5690 · Cited by 476
Miller, B. J., Appel, M. C., O'Neil, J. J., & Wicker, L. S. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.140.1.52 · Cited by 448
CD1d-restricted Recognition of Synthetic Glycolipid Antigens by Human Natural Killer T Cells
Spada, F. M., Koezuka, Y., & Porcelli, S. A. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.8.1529 · Cited by 438
Lehuen, A., Lantz, O., Beaudoin, L., Laloux, V., Carnaud, C., Bendelac, A., Bach, J.-F., & Monteiro, R. C. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.10.1831 · Cited by 393
CD28/B7 Regulation of Th1 and Th2 Subsets in the Development of Autoimmune Diabetes
Lenschow, D. J., Herold, K. C., Rhee, L., Patel, B., Koons, A., Qin, H.-Y., Fuchs, E., Singh, B., Thompson, C. B., & Bluestone, J. A. (1996) · Immunity · doi:10.1016/s1074-7613(00)80323-4 · Cited by 374
Singh, N., Hong, S., Scherer, D. C., Serizawa, I., Burdin, N., Kronenberg, M., Koezuka, Y., & Kaer, L. V. (1999) · PubMed · Cited by 358
Early quantitative and functional deficiency of NK1+‐like thymocytes in the NOD mouse
Gombert, J., Herbelin, A., Tancrède‐Bohin, E., Dy, M., Carnaud, C., & Bach, J. (1996) · European Journal of Immunology · doi:10.1002/eji.1830261226 · Cited by 358
Tissue-Specific Segregation of CD1d-Dependent and CD1d-Independent NK T Cells
Eberl, G., Lees, R., Smiley, S. T., Taniguchi, M., Grusby, M. J., & MacDonald, H. R. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.11.6410 · Cited by 324
Singh, N., Hong, S., Scherer, D. C., Serizawa, I., Burdin, N., Kronenberg, M., Koezuka, Y., & Van Kaer, L. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.5.2373 · Cited by 311
Burdin, N., Brossay, L., & Kronenberg, M. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199906)29:06<2014::aid-immu2014>3.0.co;2-g · Cited by 301
Bendelac, A. (1995) · Current Opinion in Immunology · doi:10.1016/0952-7915(95)80112-x · Cited by 285
α-Galactosylceramide-activated Vα14 natural killer T cells mediate protection against murine malaria
Gonzalez-Aseguinolaza, G., de Oliveira, C., Tomaska, M., Hong, S., Bruna-Romero, O., Nakayama, T., Taniguchi, M., Bendelac, A., Van Kaer, L., Koezuka, Y., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.15.8461 · Cited by 262
Association Between αβTCR+CD4−CD8− T-Cell Deficiency and IDDM in NOD/Lt Mice
Baxter, A. G., Kinder, S. J., Hammond, K. J. L., Scollay, R., & Godfrey, D. I. (1997) · Diabetes · doi:10.2337/diab.46.4.572 · Cited by 257
Saubermann, L. J., Beck, P., De Jong, Y. P., Pitman, R. S., Ryan, M. S., Kim, H. S., Snapper, S., Hagen, S. J., Kanauchi, O., Motoki, K., et al. (2000) · Gastroenterology · doi:10.1053/gast.2000.9114 · Cited by 210
Kumar, H., Belperron, A., Barthold, S. W., & Bockenstedt, L. K. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.9.4797 · Cited by 187
Yagi, H., Matsumoto, M., Kunimoto, K., Kawaguchi, J., Makino, S., & Harada, M. (1992) · European Journal of Immunology · doi:10.1002/eji.1830220931 · Cited by 149
Herbelin, A., Gombert, J., Lepault, F., Bach, J., & Chatenoud, L. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.5.2620 · Cited by 145
Arase, H., Arase, N., KOBAYASHI, Y., Nishimura, Y., Yonehara, S., & Onoé, K. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.180.2.423 · Cited by 141
Herbelin, A., Gombert, J., Lepault, F., Bach, J., & Chatenoud, L. (1998) · PubMed · Cited by 126
Interleukin-4 Deficiency Does Not Exacerbate Disease in NOD Mice
Wang, B., Gonzalez, A., Höglund, P., Katz, J. D., Benoist, C. O., & Mathis, D. J. (1998) · Diabetes · doi:10.2337/diab.47.8.1207 · Cited by 101
Self-citationGodfrey, D. I., Kinder, S. J., Silvera, P., & Baxter, A. G. (1997) · Journal of Autoimmunity · doi:10.1006/jaut.1997.0129 · Cited by 99
Cited by
Bendelac, A., Savage, P. B., & Teyton, L. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141711 · Cited by 2,155
THE NOD MOUSE: A Model of Immune Dysregulation
Anderson, M. S., & Bluestone, J. A. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115643 · Cited by 1,113
CD1: Antigen Presentation and T Cell Function
Brigl, M., & Brenner, M. B. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104608 · Cited by 1,035
Going both ways: Immune regulation via CD1d-dependent NKT cells
Godfrey, D. I., & Kronenberg, M. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200423594 · Cited by 877
Fuss, I. J., Heller, F., Boirivant, M., Leon, F., Yoshida, M., Fichtner-Feigl, S., Yang, Z., Exley, M., Kitani, A., Blumberg, R. S., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19836 · Cited by 797
Metadata
- Authors
- Wang, B., Geng, Y.-B., & Wang, C.-R.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2001-08-06
- Volume
- 194
- Issue
- 3
- Pages
- 313-320
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2126645919
- Cited by
- 270
- References
- 39
- FWCI
- 17.08
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.